Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Natalia Sergina, Mark M. Moasser, Megan Rausch et al.|Nature|2007Cited by 991
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic DriverDhara N. Amin, Mark M. Moasser, Kevin M. Koch et al.|Science Translational Medicine|2010Cited by 185
KRAS <sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependenciesKevin Lou, Luke A. Gilbert, Veronica Steri et al.|Science Signaling|2019Cited by 179
A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapyZiyang Zhang, Charles S. Craik, Peter J. Rohweder et al.|Cancer Cell|2022Cited by 131
Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K—mTOR pathway in pancreatic adenocarcinomaOlga K. Mirzoeva, W. Michael Korn, Byron Hann et al.|Journal of Molecular Medicine|2011Cited by 102